Carregant...
Opportunities in immunotherapy of ovarian cancer
Ovarian cancer (OC) is the most important cause of gynecological cancer-related mortality, with the majority of women presenting with advanced disease. Although surgery and chemotherapy can improve survival, the 5-year survival rates remain ominously low at 45%. Novel therapies are urgently needed....
Guardat en:
| Publicat a: | Ann Oncol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4852275/ https://ncbi.nlm.nih.gov/pubmed/27141063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdw084 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|